Intraocular bevacizumab for iris neovascularization in a silicone oil-filled eye.
OBJECTIVE
To report the effectiveness of intravitreal injection of bevacizumab for treatment of iris neovascularization in a silicone oil-filled eye.


METHODS
Case report.


METHODS
A 56-year-old man with recurrent retinal detachment associated with iris neovascularization.


RESULTS
Iris neovascularization regressed after treatment with a 1.25-mg intravitreal injection of bevacizumab in the presence of silicone oil.


CONCLUSIONS
Intraocular injection of bevacizumab is an effective short-term treatment of neovascularization caused by persistent retinal detachment even in the presence of silicone oil. The standard dose of 1.25 mg of bevacizumab may not require adjustment in an aphakic vitrectomized eye.
From the Department of Ophthalmology, University of California at San Francisco, San Francisco, California.
Ajay
A
Singh
Jay M
JM
Stewart